These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30230613)

  • 1. Impact of hepatic encephalopathy on liver transplant waiting list mortality in regions with different transplantation rates.
    Kerbert AJC; Reverter E; Verbruggen L; Tieleman M; Navasa M; Mertens BJA; Rodríguez-Tajes S; de Vree M; Metselaar HJ; Chiang FWT; Verspaget HW; van Hoek B; Bosch J; Coenraad MJ
    Clin Transplant; 2018 Nov; 32(11):e13412. PubMed ID: 30230613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
    Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.
    Lucidi C; Ginanni Corradini S; Abraldes JG; Merli M; Tandon P; Ferri F; Parlati L; Lattanzi B; Poli E; Di Gregorio V; Farcomeni A; Riggio O
    Liver Transpl; 2016 Oct; 22(10):1333-42. PubMed ID: 27434824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
    Abdallah MA; Kuo YF; Asrani S; Wong RJ; Ahmed A; Kwo P; Terrault N; Kamath PS; Jalan R; Singal AK
    J Hepatol; 2021 Jun; 74(6):1355-1361. PubMed ID: 33326814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
    van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
    J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
    Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
    Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation and waitlist mortality for HCC and non-HCC candidates following the 2015 HCC exception policy change.
    Ishaque T; Massie AB; Bowring MG; Haugen CE; Ruck JM; Halpern SE; Waldram MM; Henderson ML; Garonzik Wang JM; Cameron AM; Philosophe B; Ottmann S; Rositch AF; Segev DL
    Am J Transplant; 2019 Feb; 19(2):564-572. PubMed ID: 30312530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies.
    Labenz C; Toenges G; Schattenberg JM; Nagel M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
    Clin Transl Gastroenterol; 2020 Jun; 11(6):e00172. PubMed ID: 32568474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study.
    Lai JC; Rahimi RS; Verna EC; Kappus MR; Dunn MA; McAdams-DeMarco M; Haugen CE; Volk ML; Duarte-Rojo A; Ganger DR; O'Leary JG; Dodge JL; Ladner D; Segev DL
    Gastroenterology; 2019 May; 156(6):1675-1682. PubMed ID: 30668935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality.
    Starlinger P; Ahn JC; Mullan A; Gyoeri GP; Pereyra D; Alva-Ruiz R; Hackl H; Reiberger T; Trauner M; Santol J; Simbrunner B; Mandorfer M; Berlakovich G; Kamath PS; Heimbach J
    Hepatology; 2021 Sep; 74(3):1533-1545. PubMed ID: 33786862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current allocation policy is favorable for patients with hepatocellular carcinoma waiting for liver transplantation.
    Ferre-Aracil C; Lledó JL; Aguilera L; Garcia-Paredes A; Rodríguez-Santiago E; Graus J; García-González M; Nuño J; López-Buenadicha A; López-Hervás P; Rodríguez-Gandía M; Gea F; Albillos A
    Dig Liver Dis; 2018 Dec; 50(12):1345-1350. PubMed ID: 29807872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
    da Silva Machado AG; de Medeiros Fleck A; Marroni C; Zanotelli ML; Cantisani G; de Mello Brandão AB
    Ann Hepatol; 2013; 12(3):440-7. PubMed ID: 23619261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation.
    Northup PG; Intagliata NM; Shah NL; Pelletier SJ; Berg CL; Argo CK
    Hepatology; 2015 Jan; 61(1):285-91. PubMed ID: 24995689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis.
    Kerbert AJ; Verbeke L; Chiang FW; Laleman W; van der Reijden JJ; van Duijn W; Nevens F; Wolterbeek R; van Hoek B; Verspaget HW; Coenraad MJ
    PLoS One; 2015; 10(9):e0138264. PubMed ID: 26378453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with severe acute-on-chronic liver failure are disadvantaged by model for end-stage liver disease-based organ allocation policy.
    Sundaram V; Shah P; Mahmud N; Lindenmeyer CC; Klein AS; Wong RJ; Karvellas CJ; K Asrani S; Jalan R
    Aliment Pharmacol Ther; 2020 Oct; 52(7):1204-1213. PubMed ID: 32725664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ferritin concentration predicts mortality in patients awaiting liver transplantation.
    Walker NM; Stuart KA; Ryan RJ; Desai S; Saab S; Nicol JA; Fletcher LM; Crawford DH
    Hepatology; 2010 May; 51(5):1683-91. PubMed ID: 20225256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
    Wong RJ; Gish RG; Ahmed A
    Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre and post-liver transplant outcome of cirrhotic patients with acute on chronic liver failure.
    Iacob S; Ghioca M; Csiki IE; Tomescu D; Droc G; Hrehoret D; Brasoveanu V; Pietrareanu C; Iacob R; Gheorghe C; Popescu I; Gheorghe L
    Medicine (Baltimore); 2020 Oct; 99(44):e22419. PubMed ID: 33126299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared With Cryptogenic, Alcoholic, or AIH Cirrhosis.
    Thuluvath PJ; Hanish S; Savva Y
    Transplantation; 2019 Jan; 103(1):113-121. PubMed ID: 29985186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation.
    Samuel D; Coilly A
    BMC Med; 2018 Aug; 16(1):113. PubMed ID: 30064414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.